ProQR to present at SMi’s RNA Therapeutics 2019 after their latest development of a RNA-based oligonucleotide to treat vision loss Read more
FDA Approves ONTRUZANT (trastuzumab-dttb), Samsung Bioepis’ First Oncology Medicine in the United States Read more
FDA advisory committee votes on Zynquista (sotagliflozin) as treatment for adults with type 1 diabetes Read more
Genentech develop Antibiotic effective against Gram-negative Bacteria, with potential to lead to new class of Antibiotics Read more
Putting worker safety and product quality at the forefront of the HPAPI Industry – Highly Potent Active Pharmaceutical Ingredients 2019 Read more
Linzess (linaclotide) approved in China for the treatment of irritable bowel syndrome with constipation Read more